This event is archived. Final snapshot from when the story concluded. View on Dashboard
Business debt settlement

Diagnos Settles Debt with Shares

Analysis based on 8 articles · First reported Jun 18, 2026 · Last updated Jun 18, 2026

Sentiment
10
Attention
2
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The market impact on Diagnosis is likely mixed; while the company preserves cash by issuing shares, this action will dilute existing shareholder value. The settlement is subject to regulatory approval from the TSX Venture Exchange, which could influence investor confidence.

Healthcare Technology

Diagnosis, a publicly traded Canadian corporation focused on AI for eye-related health, announced its intention to settle two demand loans totaling C$125,000. The settlement will involve issuing 625,000 common shares at C$0.20 per share to the lenders, with accrued interest paid in cash. This move is intended to preserve Diagnosis's cash reserves. The agreements were dated June 18, 2026, with an anticipated settlement date of June 25, 2026. The transaction is contingent on regulatory acceptance from the TSX Venture Exchange.

exch
The TSX Venture Exchange's acceptance is required for the debt settlement to proceed, indicating its regulatory role in the transaction.
Importance 50.0 Sentiment 0.0
curr
The loans and share price are denominated in Canada — Canadian dollars, making it the currency of transaction for this event.
Importance 20.0 Sentiment 0.0
per
André Larente is the President of Diagnosis and a contact person for further information regarding the debt settlement.
Importance 10.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.